|
Market Cap (17-May) $36,803,800 (436th) |
Close (30-Jun) $0.310 |
Volume (30-Jun) 965,700 |
Shortsold (5-May) 630,735 (0.15%) (400th) |
|
52w High $0.130 |
52w Low $0.086 |
P/E 312.50 |
EPS -0.03 |
SPL released this announcement to the ASX on 26 August 2021, 9:39. The announcement is not marked as price sensitive, and is 15 page(s) in length and 401.05kb in size.
You can view all announcements from SPL and see how they appear on a price chart on the announcements page.
At the date of this announcement, SPL was 2.425% short sold according to ASIC data. It was ranked the 68th most shorted stock on the ASX. It remains ranked 400th as of the latest reported data (05 May 2025).
| Other Recent Announcements from SPL | |
|---|---|
| Clinical Trial Update | 27 June 2023, 9:57 |
| Life Sciences Investor Forum Presentation | 23 June 2023, 10:42 |
| Starpharma to present at Life Sciences Investor Forum | 22 June 2023, 12:48 |
| Appendix 4G - Corporate Governance Statement | 26 August 2021, 9:39 |
| Starpharma annual report and full year financial results | 26 August 2021, 9:28 |
| VIRALEZE Protects Against SARS-CoV-2 in Challenge Model | 23 August 2021, 10:23 |
| VIRALEZE well tolerated in multiple dose clinical study | 17 August 2021, 10:29 |
You must be logged in to post a reply.
Starpharma Holdings 